HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 183 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,533,400 | +10.2% | 1,420,000 | +18.3% | 0.11% | +15.2% |
| Q2 2023 | $42,228,000 | -8.6% | 1,200,000 | -15.2% | 0.09% | -11.5% |
| Q1 2023 | $46,199,750 | +545.0% | 1,415,000 | +988.5% | 0.10% | +511.8% |
| Q4 2022 | $7,163,000 | -72.6% | 130,000 | -78.0% | 0.02% | -73.8% |
| Q3 2022 | $26,131,000 | -48.2% | 590,000 | -43.0% | 0.06% | -44.0% |
| Q2 2022 | $50,450,000 | -8.4% | 1,034,450 | -8.6% | 0.12% | +10.5% |
| Q1 2022 | $55,082,000 | -26.2% | 1,132,216 | -35.3% | 0.10% | -21.6% |
| Q4 2021 | $74,620,000 | +56.9% | 1,750,000 | +41.1% | 0.13% | +42.6% |
| Q3 2021 | $47,545,000 | – | 1,240,415 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |